Prostate Cancer Patients
Oncology·MeSH: Prostatic Neoplasms
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Phase 2(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Prostate Cancer Patients?
BioSniper tracks 2 drugs in development for Prostate Cancer Patients across 2 companies.
How many clinical trials target Prostate Cancer Patients?
There are 2 clinical trials targeting Prostate Cancer Patients tracked by BioSniper.
What is the prevalence of Prostate Cancer Patients?
The estimated prevalence of Prostate Cancer Patients is approximately 256.0 per 100,000 population.
Deep-dive into Prostate Cancer Patients
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis